Silexion Therapeutics LTD (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

1.00

0.02 (1.54%)

At close: May 01, 2025, 3:59 PM

0.99

-0.99%

After-hours: May 01, 2025, 05:46 PM EDT

Silexion Therapeutics LTD Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-16.52M	-5.11M	-3.49M
Depreciation & Amortization	25K	45K	57K
Stock-Based Compensation	5.86M	130K	125K
Other Working Capital	319K	-10K	317K
Other Non-Cash Items	3.82M	317K	-268K
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	-1.58M	87K	239K
Operating Cash Flow	-8.4M	-4.53M	-3.33M
Capital Expenditures	-22K	-12K	-40K
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-500K
Sales Maturities Of Investments	n/a	507K	16K
Other Investing Acitivies	n/a	78K	n/a
Investing Cash Flow	-22K	573K	-524K
Debt Repayment	-250K	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	2.3M	n/a	3K
Financial Cash Flow	5.1M	522K	2.75M
Net Cash Flow	-3.38M	-3.66M	-1.77M
Free Cash Flow	-8.42M	-4.54M	-3.38M